Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

Early hair loss may be linked to metabolic syndrome.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Genetics and nutritional deficiencies are key factors in premature graying of hair.

Iron and zinc deficiencies may be treated to help female hair loss.

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Povidone-iodine nail solution effectively treats nail infections caused by chemotherapy.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

There is no significant link between alopecia areata and the PON1 enzyme polymorphisms studied.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

The conclusion is that 24 weeks of low-dose oral minoxidil is safe for men with hair loss, with no significant changes in heart rate or blood pressure.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Drinking sweetened tea and soda and poor sleep may increase the risk of hair loss in women.